Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-02-13-Speech-1-066-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-02-13"^^xsd:date2
dcterms:Is Part Of	lp_eu:Office for Harmonisation in the Internal Market (Trade Marks and Designs) and protection of intellectual property rights (debate)2
dcterms:Language	"sk"^^xsd:language2
lpv:document identification number	"en.20120213.15.1-066-000"2
lpv:hasSubsequent	lp_eu:2012-02-13-Speech-1-067-0002
lpv:speaker	lp:Monika Beňová2
lpv:spokenAs	unknown; SMER-Sociálna demokracia (2009-07-14--2014-06-30)3 member; Delegation for relations with Israel (2009-09-16--2014-06-30)3 member; S&D (2012-01-19--2014-06-30)3 substitute; AFET (2012-01-19--2014-06-30)3 member; LIBE (2012-01-19--2014-06-30)3
lpv:translated text	"Mr President, issues of intellectual property protection have recently become highly politicised, and have come to the forefront of public interest due to the disputed ACTA agreement. On this occasion, I would like to raise the question of whether the current patent protection is the most effective and the fairest possible. I would like to mention in particular the patent law that allows pharmaceutical companies to sell drugs for fatal diseases at a high price. Moreover, under the threat of sanctions, they can prevent the production and sale of far cheaper generic drugs. Technically, therefore, it is not a problem to prevent the death of people, but legally it is impossible, because the pharmaceutical corporations do not want to give up their profits from sales and are preventing the attainment of what is technically possible. The existence of the patent in its present form thus leads directly to the needless death and suffering of many people."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph